As of 2025-07-19, the Fair Value of Tarsus Pharmaceuticals, Inc. (TARS) is -12.49 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 43.25 USD, the upside of Tarsus Pharmaceuticals, Inc. is -128.88%.
With the market price of 43.25 USD and our fair value calculation, Tarsus Pharmaceuticals, Inc. (TARS) is not a good investment. Investing in TARS stocks now will result in a potential loss of 128.88%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -26.81 | -13.83 | -62.09 | -135.89 | -115.55 | -70.84 |
| YoY growth | -474.09% | 48.41% | -348.95% | -118.86% | 14.97% | -175.70% |
| Market Cap (mil) | 1,816.93 |
| P/E | |
| Forward P/E |
| EPS | -2.50 |
| Avg earnings growth rate | -175.70% |
| TTM earnings | -104.94 |